The risk of saying yes to Soriot's pay rise is mitigated by the promise of a dividend boost hours before the vote

Vote to reject remuneration deepens concerns over London stock market exodus. AstraZeneca hit by investor backlash over chief Pascal Soriot’s £19m pay deal. AstraZeneca has been hit by backlash over CEO's £19million salary.

Pascal Soriot’s £18.7m package opens door to likelihood of US-style executive pay elsewhere. Despite rebellion, approval of £18m package opened door to chance of similar pay rises elsewhere. AstraZeneca boss Pascal Soriots' pay rise opens door for US-like executive pay in UK.

AstraZeneca promises boost amid vote on Pascal Soriot's pay at annual general meeting. Shareholders gear up to vote on the firm's chief executive's pay package at its annual meeting today. Company promises boost as they gear up for vote on pay package today.

Drugmaker announces 7% increase as it seeks to garner support for Pascal Soriot’s £1.8m pay boost. Drugmaker also promises £19m pay-deal for boss. Pascal's pay deal set to be voted in favour of by shareholders on Monday.

The drugmaker was on its knees when Sir Pascal Soriot took over in 2012. Under his leadership it now does just about everything the UK wants from a business. He could earn £18.5m this year - but he may be underpaid. The company is creating high value-added jobs and developing products that improve people's lives.